Position in ROIV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,306,315
+$273,438 QoQ
Shares Held
36,912
-1.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#220
of 494 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VestGen Advisors, LLC holds $4,407,229 across 7 Biotechnology names. ROIV ranks #1 (29.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
36,912 | $1,306,315 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,199 | $1,092,309 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
13,126 | $1,069,900 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,451 | $731,868 | |
| 5 | ABCL |
AbCellera Biologics Inc.
|
19,652 | $154,268 | |
| 6 | IMRX |
Immuneering Corp
|
10,000 | $49,900 | |
| 7 | GOSS |
Gossamer Bio, Inc.
|
16,177 | $2,669 |
All Filings in ROIV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,306,315 | 36,912 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,032,877 | 37,288 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $521,082 | 24,013 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||